- Global Pharma News & Resources

Lipopolysaccharides Immunoassays Market is projected to accelerate at a CAGR of 3.4% from 2023 to 2032 | insightSLICE

The global Lipopolysaccharides Immunoassays market size was estimated to be US$ 1.24 billion in 2021 and is expected grow at a CAGR of 3.4% between 2023 to 2032.

It is anticipated that lipopolysaccharides immunoassays would grow adaptively during the forecast report. This primary expansion is associated with the introduction of point-of-care testing kits for lipopolysaccharide immunoassays. Several key players in this industry employ tactics like this to ensure market growth.

The quantification of the lipopolysaccharide produced by P. gingivalis has become a crucial indicator for both dental hygiene and the overall health of the body because of the strong association between this type of bacteria and other serious health problems, such as heart disease and the neurodegenerative disease like Alzheimer’s.

Access the sample report:

The key players of the Global Lipopolysaccharides Immunoassays Market are:

AdVnt Biotechnologies, BioChek (BIOTECON Diagnostics), Bio-Techne, Fisher Scientific (THERMO), New Horizons Diagnostic Corporation, Response Biomedical, and a few more are major companies with footprints in the global lipopolysaccharides immunoassay market.

Key market participants work to reach target customers with efficient approaches, like offering kits that allow for the early diagnosis of disease infections. Key market participants are adopting innovative product development tactics like intellectual property protection and licensing in order to provide viable goods that are beneficial to patient care.

Driving factors for the growth of Global Lipopolysaccharides Immunoassays Market

Lipopolysaccharide immunoassays are expected to play a major role in the detection of LPS biomarkers produced by various diseases in the coming decade. The increasing burden of contagious diseases would indeed be one major factor influencing this development.

A distinct point-of-care device that can be used for both regular PG LPS level detection and early identification is clearly in demand due to the growing impact of P. gingivalis LPS.

Traditional qualitative characterization of bacterial indicators frequently makes use of the well-known PCR technology, requiring the expertise of qualified individuals and extensive time spent in a laboratory.

For the detection of lipopolysaccharides, a number of cutting-edge methods have been developed, including the use of lipid bilayers, anti-microbial, synthetic polymers, optical immunoassays, waveguide technology, aptamers, in vitro assays and electrochemical impedance spectroscopy (EIS).

The absence of alternate strategies for lipopolysaccharide analysis limits the marketplace for lipopolysaccharides immunoassays in general.

Interest in testing for infectious diseases has grown since the unprecedented coronavirus pandemic began in 2020. Sales and manufacturing of immunoassay kits and chemicals have expanded as a result, and the market is anticipated to expand quickly over the coming years as a result of advancements in clinical research techniques.

Read more about the report inclusions:

Global Lipopolysaccharides Immunoassays Market Key Segments:

By Product Type:

  • Immunoassay Kits & Reagents
  • Kits
  • Primary Antibodies
  • Secondary Antibodies
  • Immunoassay Substrates
  • Immunoassay Buffers
  • Analysers & Instruments
  • Consumables
  • Software

By Assay:

  • FIA
  • CLIA
  • LFA
  • Others

By Purpose:

  • Research Use Only
  • Clinical Use

By Application:

  • Clinical Diagnostics
  • Drug Discovery
  • Screening of diseases & disorders

By End User:

  • Human Use
  • Veterinary

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Related reports:

Global Audiology Devices Market:

Global Anti-adrenergic Agent Market:

Regional performance of Lipopolysaccharides Immunoassays Market

In 2021, the U.S. held a 30.3% market share in the worldwide lipopolysaccharides immunoassay market, and it is anticipated that this trend will continue during the forecast period.

This can be linked to two things: the ease with which technologically sophisticated tests are available, as well as the increased demand for diagnostics brought on by the rise in cancer incidence.

The demand for diagnosis and treatment is also being driven by the high frequency of infectious diseases in the nation, including Aids, Tuberculosis, and pneumonia.

In 2021, Germany held a 6% market share for lipopolysaccharides immunoassays worldwide. Clinical studies are being carried out extensively in Germany by a large number of reputable players to evaluate the efficacy of biopharmaceutical drugs intended for human use.

China also held a market share of 8.1% for lipopolysaccharides immunoassays globally. The country’s increasing number of new coronavirus infections compelled manufacturers to put more effort into creating immunoassay kits and reagents for pathogen assessment in order to start the healing process.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 23-Nov-2022